Skip to content
AwardedSpainGoods€5,891,388

Suministro de Fenilbutirato de Na (DOE), Fenilbutirato Glicerilo (DOE), Paclitaxel (DOE) unido a alb en formulación de nanopartículas, Povidona (DOE), Pantoprazol (DOE), Axitinib(DOE) y Maraviroc(DOE)

Published
Published 10 September 2025
Deadline
Closed 10 October 2025

Overview

Suministro de Fenilbutirato de Na (DOE), Fenilbutirato Glicerilo (DOE), Paclitaxel (DOE) unido a alb en formulación de nanopartículas, Povidona (DOE), Pantoprazol (DOE), Axitinib(DOE) y Maraviroc(DOE)

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€5,891,388
Procedure
Open
Published
10 September 2025
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€732,237
Award date
23 January 2026
Contract period
24 January 2026 → 23 January 2027
Winners
  • ACCORD HEALTHCARE, S.L.U.
  • Eurocept international B.V.
  • HIKMA ESPAÑA S.L.U.
  • IMMEDICA PHARMA AB
  • LABORATORIOS NORMON, S.A.
  • TARBIS FARMA SL
  • TEVA PHARMA, S.L.
  • ZENTIVA SPAIN SLU

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    27 January 2026

  2. Contract Notice

    10 September 2025

Contracting authority

  • OSAKIDETZA - Servicio Vasco de Salud - Organización Central

    Procuring entity

    Vitoria-Gasteiz, Spain

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro de Fenilbutirato de Na (DOE), Fenilbutirato Glicerilo (DOE), Paclitaxel (DOE) unido a alb en formulación de nanopartículas, Povidona (DOE), Pantoprazol (DOE), Axitinib(DOE) y Maraviroc(DOE) — won by ACCORD HEALTHCARE, S.L.U. +7 — Skim